Additional file 1 of Combination of GT90001 and nivolumab in patients with advanced hepatocellular carcinoma: a multicenter, single-arm, phase 1b/2 study

Abstract

Additional file 1: Appendix Table 1. Complete eligibility criteria. Appendix Table S2. Details of dose reduction or interruption due to treatment-emergent adverse events in all patients. Appendix Figure S1. Study procedures. Appendix Figure S2. Changes in patient blood pressure. (A) Changes in blood pressure between baseline and at the end of study drug treatment. (B) The percentage of patients who experienced a change in blood pressure. Abbreviations: SBP=systolic blood pressure; DBP=diastolic blood pressure